Can Cardiovascular Risk Factors Be Predicted? The Case of Weight-Adjusted Waist Index.
作者信息
Borghi Claudio, Fiorini Giulia
机构信息
Department of Cardiovascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy.
出版信息
J Clin Hypertens (Greenwich). 2025 May;27(5):e70074. doi: 10.1111/jch.70074.
Abstract
摘要
相似文献
1
Can Cardiovascular Risk Factors Be Predicted? The Case of Weight-Adjusted Waist Index.心血管危险因素能够被预测吗？以体重校正腰围指数为例。
J Clin Hypertens (Greenwich). 2025 May;27(5):e70074. doi: 10.1111/jch.70074.
2
Weight-adjusted waist index as a practical predictor for diabetes, cardiovascular disease, and non-accidental mortality risk.体重调整腰围指数作为糖尿病、心血管疾病和非意外死亡率风险的实用预测指标。
Nutr Metab Cardiovasc Dis. 2024 Nov;34(11):2498-2510. doi: 10.1016/j.numecd.2024.06.012. Epub 2024 Jun 24.
3
The association of weight-adjusted waist index with the risk of osteoporosis in patients with type 2 diabetes: a cross-sectional study.体重调整腰围指数与 2 型糖尿病患者骨质疏松风险的相关性：一项横断面研究。
J Orthop Surg Res. 2024 Aug 29;19(1):518. doi: 10.1186/s13018-024-04991-7.
4
Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: evidence from middle-aged and older individuals.甘油三酯-血糖-体重调整腰围指数的基线和变化与心血管疾病风险的关联：来自中年及以上人群的证据。
Cardiovasc Diabetol. 2024 Nov 18;23(1):415. doi: 10.1186/s12933-024-02511-9.
5
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018.体重调整腰围指数与代谢功能障碍相关脂肪性肝病患者的全因和心血管死亡率呈正线性相关：来自 NHANES 1999-2018 的研究结果。
Front Endocrinol (Lausanne). 2024 Sep 30;15:1457869. doi: 10.3389/fendo.2024.1457869. eCollection 2024.
6
Association of weight-adjusted-waist index with all-cause and cardiovascular mortality in China: A prospective cohort study.体重调整腰围指数与全因和心血管死亡率的关联在中国：一项前瞻性队列研究。
Nutr Metab Cardiovasc Dis. 2022 May;32(5):1210-1217. doi: 10.1016/j.numecd.2022.01.033. Epub 2022 Feb 3.
7
The association between weight-adjusted waist circumference index and cardiovascular disease and mortality in patients with diabetes.体重调整腰围指数与糖尿病患者心血管疾病和死亡率的关系。
Sci Rep. 2024 Aug 16;14(1):18973. doi: 10.1038/s41598-024-69712-w.
8
The weight-adjusted-waist index predicts all-cause and cardiovascular mortality in general US adults.体重调整腰围指数可预测美国普通成年人的全因死亡率和心血管死亡率。
Clinics (Sao Paulo). 2023 Jul 11;78:100248. doi: 10.1016/j.clinsp.2023.100248. eCollection 2023.
9
Anthropometric indicators and cardiovascular diseases risk in pre-diabetic and diabetic adults: NHANES 1999-2018 cross-sectional analysis.在糖尿病前期和糖尿病成人中，人体测量指标与心血管疾病风险：NHANES 1999-2018 横断面分析。
Exp Gerontol. 2024 Sep;194:112516. doi: 10.1016/j.exger.2024.112516. Epub 2024 Jul 10.
10
Waist circumference reduction and cardiovascular benefits during weight loss in women.女性减肥期间腰围减小与心血管益处
Int J Obes Relat Metab Disord. 1997 Feb;21(2):127-34. doi: 10.1038/sj.ijo.0800377.
本文引用的文献
1
Weight-Adjusted Waist Index May Predict Hypertension Plus Hyperuricemia.体重调整腰围指数可能预测高血压合并高尿酸血症。
J Clin Hypertens (Greenwich). 2025 Mar;27(3):e70022. doi: 10.1111/jch.70022.
2
Definition and diagnostic criteria of clinical obesity.临床肥胖的定义和诊断标准。
Lancet Diabetes Endocrinol. 2025 Mar;13(3):221-262. doi: 10.1016/S2213-8587(24)00316-4. Epub 2025 Jan 14.
3
Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off.尿酸与代谢综合征：高尿酸血症切点的重要性。
Int J Cardiol. 2024 Dec 15;417:132527. doi: 10.1016/j.ijcard.2024.132527. Epub 2024 Sep 5.
4
Association of the weight-adjusted waist index with hypertension in the context of predictive, preventive, and personalized medicine.在预测、预防和个性化医学背景下体重调整腰围指数与高血压的关联
EPMA J. 2024 Aug 10;15(3):491-500. doi: 10.1007/s13167-024-00375-3. eCollection 2024 Sep.
5
Weight-adjusted waist index as a practical predictor for diabetes, cardiovascular disease, and non-accidental mortality risk.体重调整腰围指数作为糖尿病、心血管疾病和非意外死亡率风险的实用预测指标。
Nutr Metab Cardiovasc Dis. 2024 Nov;34(11):2498-2510. doi: 10.1016/j.numecd.2024.06.012. Epub 2024 Jun 24.
6
Natural mutations of human XDH promote the nitrite (NO)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?人类 XDH 的自然突变促进黄嘌呤氧化还原酶的亚硝酸盐（NO）还原酶活性：促进氧化还原健康的新机制？
Redox Biol. 2023 Nov;67:102864. doi: 10.1016/j.redox.2023.102864. Epub 2023 Sep 4.
7
Association of Normal Serum Uric Acid Level and Cardiovascular Disease in People Without Risk Factors for Cardiac Diseases in China.中国无心脏病风险因素人群中正常血清尿酸水平与心血管疾病的关系。
J Am Heart Assoc. 2023 May 16;12(10):e029633. doi: 10.1161/JAHA.123.029633. Epub 2023 May 15.
8
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation.肥胖与心血管疾病：机制洞察与管理策略。世界心脏联盟和世界肥胖联盟联合立场文件。
Eur J Prev Cardiol. 2022 Dec 7;29(17):2218-2237. doi: 10.1093/eurjpc/zwac187.
9
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.尿酸与高血压：心血管风险管理的证据回顾及未来展望。
Hypertension. 2022 Sep;79(9):1927-1936. doi: 10.1161/HYPERTENSIONAHA.122.17956. Epub 2022 Jun 6.
10
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.全球高血压患病率趋势及 1990 至 2019 年治疗和控制进展情况：1040 万参与者、1201 项人群代表性研究的汇总分析
Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.
Zotero 插件